Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes

NCT00208221 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

50

Enrollment

OTHER

Sponsor class

Stopped Not enough recruitment

Conditions

Hypertension
Type 2 Diabetes
Albuminuria

Interventions

DRUG: ramipril
DRUG: ramipril-telmisartan

Sponsor

Institut de Recherches Cliniques de Montreal